Federation des caisses Desjardins du Quebec’s Global X Genomics & Biotechnology ETF GNOM Stock Holding History
Bought
Maintained
Sold
Other funds holding GNOM
OAM
AAP
SWP
CFD
FIA
Federation des caisses Desjardins du Quebec's GNOM Position: Q2 2026 in Review
Federation des caisses Desjardins du Quebec reduced its Global X Genomics & Biotechnology ETF (GNOM) stake by 4.8% in Q2 2026, selling an estimated $3.24K and leaving 1,347 shares worth $76.4K. The position accounts for ﹤0.01% of the portfolio, ranked #1815.
Federation des caisses Desjardins du Quebec first reported a position in GNOM in Q1 2021 and has held it in 22 quarters since. 48 funds tracked by Wall St. Rank hold GNOM as of Q2 2026.
- Federation des caisses Desjardins du Quebec held 1,347 shares of Global X Genomics & Biotechnology ETF worth $76.4K as of Q2 2026.
- Federation des caisses Desjardins du Quebec sold 68 Global X Genomics & Biotechnology ETF shares in Q2 2026, an estimated $3.24K.
- Global X Genomics & Biotechnology ETF made up ﹤0.01% of Federation des caisses Desjardins du Quebec's portfolio in Q2 2026, its #1815 holding.
- Federation des caisses Desjardins du Quebec first reported a position in Global X Genomics & Biotechnology ETF in Q1 2021 and has held it in 22 quarters since.
- 48 funds tracked by Wall St. Rank held Global X Genomics & Biotechnology ETF as of Q2 2026.
Based on Federation des caisses Desjardins du Quebec's 13F filing for Q2 2026, filed 14 Aug 2026.